Anavex Life Sciences (AVXL) Other Non Operating Income (2016 - 2025)
Anavex Life Sciences (AVXL) reported Other Non Operating Income of $7000.0 for Q4 2025, up 102.08% on a YoY basis from $3464.0 in Q4 2024, and up 40.0% sequentially from $5000.0 in Q3 2025.
Anavex Life Sciences (AVXL) Other Non Operating Income (2016 - 2025) Analysis & Trends
Anavex Life Sciences (AVXL) has 10 years of Other Non Operating Income data on file, last reported at $7000.0 in Q4 2025.
- For the quarter ending Q4 2025, Other Non Operating Income rose 102.08% year-over-year to $7000.0; the trailing twelve-month figure through Dec 2025 stood at $12000.0 (up 103.96% YoY), and the FY2025 full-year result was -$332000.0, down 275.66% from the prior year.
- Other Non Operating Income climbed to $7000.0 in Q4 2025, from $5000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $366000.0 in Q4 2022 to a low of -$732549.0 in Q2 2022.
- A 5-year average of -$76531.7 and a median of -$25500.0 in 2023 frame the typical range for Other Non Operating Income.
- Peak annual rise in Other Non Operating Income reached 561.09% in 2022, while the deepest fall reached 355.34% in 2022.
- Tracing AVXL's Other Non Operating Income over 5 years: stood at $55363.0 in 2021, then surged by 561.09% to $366000.0 in 2022, then sank by 57.38% to $156000.0 in 2023, then plunged by 316.03% to -$337000.0 in 2024, then surged by 102.08% to $7000.0 in 2025.
- Business Quant data shows AVXL's Other Non Operating Income at $7000.0 in Q4 2025, $5000.0 in Q3 2025, and -$11000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Anavex Life Sciences | 223.91 Mn | 92.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Jun 30, 2025 | -11,000.00 |
| Mar 31, 2025 | 11,000.00 |
| Dec 31, 2024 | -337,000.00 |
| Sep 30, 2024 | 117,000.00 |
| Jun 30, 2024 | 67,000.00 |
| Mar 31, 2024 | -150,000.00 |
| Dec 31, 2023 | 156,000.00 |
| Sep 30, 2023 | -40,000.00 |
| Jun 30, 2023 | -101,000.00 |
| Mar 31, 2023 | -118,000.00 |
| Dec 31, 2022 | 366,000.00 |
| Sep 30, 2022 | -495,459.00 |
| Jun 30, 2022 | -732,549.00 |
| Mar 31, 2022 | 268,645.00 |
| Dec 31, 2021 | 55,363.00 |
| Sep 30, 2021 | -283,191.00 |
| Jun 30, 2021 | -160,880.00 |
| Mar 31, 2021 | -154,563.00 |